June 7 (Reuters) - Nyxoah SA NYXH.BR :
* NYXOAH BETTER SLEEP TRIAL REACHES ITS PRIMARY ENDPOINTS
* EXPECTS TO ANNOUNCE ADDITIONAL DATA WITH RESPECT TO STUDY AS FURTHER
ANALYSES
ARE CONDUCTED
* TOP-LINE RESULTS FROM BETTER SLEEP STUDY SHOWED:
* A STATISTICALLY SIGNIFICANT MEAN REDUCTION IN APNEA HYPOPNEA INDEX (AHI)
FROM
BASELINE TO SIX MONTHS POST IMPLANTATION IN WHOLE COHORT (CCC AND NON-CCC
PATIENTS)
* A STATISTICALLY SIGNIFICANT MEAN REDUCTION IN AHI FROM BASELINE TO SIX
MONTHS
POST IMPLANTATION IN CCC PATIENT SUBGROUP
* 42.9% OF STUDY POPULATION HAD CCC
Source text for Eikon: ID:nGNE6qQNbF
Further company coverage: NYXH.BR
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))